Burns
Volume 35, Issue 8 , Pages 1165-1170 , December 2009

Enhancement effect of terpenes on silver sulphadiazine permeation through third-degree burn eschar

  • Hamid R. Moghimi

      Affiliations

    • Department of Pharmaceutics, School of Pharmacy, Shaheed Beheshti Medical University, Tehran, Iran
    • Corresponding Author InformationCorresponding author at: School of Pharmacy, Shaheed Beheshti Medical University, Valiasr Ave., Niayesh Junction, PO Box 14155-6153, Tehran, Iran. Tel.: +98 21 88200074; fax: +98 21 88209620.
    • ,
  • Behzad S. Makhmalzadeh

      Affiliations

    • Department of Pharmaceutics, School of Pharmacy, Shaheed Beheshti Medical University, Tehran, Iran
    • Present address: Department of Pharmaceutics, School of Pharmacy, Jundishapur University of Medical Sciences, Ahwaz, Iran.
    • ,
  • Ali Manafi

      Affiliations

    • Department of Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

,Accepted 16 February 2009.

References 

  1. Luterman A, Dacso CC, Curreri PW. Infections in burns patients. Am J Med. 1986;81:45–52
  2. Pruitt BA, McManus AT, Kim SH, Goodwin CW. Burn wound infections, current status. World J Surg. 1998;22:135–145
  3. Wibbenmeyer L, Danks R, Faucher L, Amelon B, Kealey GP, Herwaldt LA. Prospective analysis of nosocomial infection rates, antibiotic use and patterns of resistance in burn populations. J Burn Care Res. 2006;27:152–160
  4. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19:403–434
  5. Edwards JV, Bopp AF, Batistie SL, Goynes WR. Human neutrophil elastase inhibition with a novel cotton-alginate wound dressing formulation. J Biomed Mater Res A. 2003;66:433–440
  6. Monafo WW, West MA. Current treatment recommendation for topical burn therapy. Drugs. 1990;40:364–373
  7. Monafo WW, Bessey PQ. Wound care. In:  Herendon DN editors. Topical burn care. London: Saunders; 2002;p. 109–119
  8. Hunt JL, Sato R, Baxter CR. Early tangential excision and immediate mesh autografting of deep dermal hand burns. Ann Surg. 1979;189:147–151
  9. Pruitt BA, Moncrief JA. Current trends in burn research. J Surg Res. 1967;7:280–293
  10. Yurt RW, McManus AT, Mason AD, Pruitt BA. Increased susceptibility to infection related to extend of burn injury. Arch Surg. 1984;119:183–188
  11. Scott JR, Watson SB. Surgical management of burns. In:  Kinsella J editors. Burns. London: Baillière Tindall; 1997;p. 473–495
  12. Press B. Thermal and electrical injuries. In:  Smith JW,  Aston SJ editor. Grabb and Smith's plastic surgery. 4th ed.. Boston: Little, Brown and Company; 1991;p. 675–730
  13. Wassermann D, Scholtterer M, Leberton F, Levy J, Guelfi MC. Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. Burns. 1989;15:257–260
  14. Monafo WW, Freedman B. Topical therapy for burns. Surg Clin North Am. 1987;67:133–145
  15. Schwartz K. Burn wound infection. Eur Med J. 2002;3:1–9
  16. Ward RS, Saffle JR. Topical agents in burn and wound care. Phys Ther. 1995;75:526–538
  17. Herruzo-Cabrera R, Gracia-Torres V, Rey-Calero J, Vizcaino-Alcaide MJ. Evaluation of the penetration strength, bactericidal efficacy and spectrum of action of several antimicrobial creams against isolated microorganisms in a burn centre. Burns. 1992;18:39–44
  18. Moghimi HR, Manafi A, Hashemlou A. Effects of water and other enhancers on the permeation of drugs through burn eschar. In:  Brain KR,  Walters KA editor. Abstracts of Presentations at the 6th International Conference of Perspectives in Percutaneous Penetration held in Leiden, vol. 6a. The Netherlands, September 1998. Cardiff: STS Publishing; 1998;p. 35
  19. Manafi A, Hashemlou A, Momeni P, Moghimi HR. Enhancing drugs absorption through third-degree burn wound eschar. Burns. 2008;34:698–702
  20. Sharif Makhmal Zadeh B, Moghimi H. Effect of hydration on barrier performance of third-degree burn eschar. Ir J Pharm Res. 2006;3:155–161
  21. Williams AC, Barry BW. Terpenes and the lipid–protein-partition theory of skin penetration enhancement. Pharm Res. 1991;8:17–24
  22. Williams AC, Barry BW. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int J Pharm. 1991;74:157–168
  23. Cornwell PA, Barry BW. Sesquiterpenes components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J Pharm Pharmacol. 1994;46:261–269
  24. Gelone S, O’Donnell JA. Anti-infectives. In:  Troy DB editors. Remington, the science and practice of pharmacy. 21st ed.. Philadelphia: Lippincott Williams & Wilkins; 2006;p. 1626–1684
  25. Barry BW, Bennett SL. Effect of penetration enhancers on the permeation of manitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol. 1987;39:535–546
  26. Barry BW. Transdermal drug delivery. In:  Aulton ME editors. Aulton's pharmaceutics. 3rd ed.. Edinburgh: Churchill Livingstone-Elsevier; 2007;p. 565–597
  27. Zhao K, Singh HJ. Mechanisms of in vitro percutaneous absorption enhancement of tamoxifen by enhancers. J Pharm Sci. 2000;89:771–780
  28. EL-Kattan AF, Asbill CS, Kim N, Michniak BB. The effect of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm. 2001;215:229–240
  29. Moghimi HR, Williams AC, Barry BW. A lamellar matrix model for stratum corneum intercellular lipids. IV. Effects of terpene penetration enhancers on the permeation of 5-fluorouracil and oestradiol through the matrix. Int J Pharm. 1996;145:49–59
  30. Moghimi HR, Williams AC, Barry BW. Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach. J Pharm Pharmacol. 1998;50:955–964
  31. Okabe H, Takayama K, Ogura A, Nagai T. Effect of limonene and related compounds on percutaneous absorption of indomethacin. Drug Des Deliv. 1989;4:313–321
  32. Hori M, Satoh S, Maibach HI, Guy RH. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J Pharm Sci. 1991;80:32–35
  33. EL-Kattan AF, Asbill CS, Michniak BB. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm. 2000;198:179–189
  34. Opdyke DLJ. Monographs of fragrance raw materials. Food Cosmet Toxicol. 1974;12:703–704
  35. Opdyke DLJ. Monographs of fragrance raw materials: eucalyptol. Food Cosmet Toxicol. 1975;13:103–104
  36. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils—a review. Food Chem Toxicol. 2008;46:446–475

PII: S0305-4179(09)00069-2

doi: 10.1016/j.burns.2009.02.006

Burns
Volume 35, Issue 8 , Pages 1165-1170 , December 2009

Article Tools

* Image Usage & Resolution